Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
Open accessThe DOI matches its Crossref record; 50 of the 52 references it cites were found in a registry or an index.
Abstract
The human gastro-intestinal tract hosts a complex and diverse microbial community, whose collective genetic coding capacity vastly exceeds that of the human genome. As a consequence, the gut microbiota produces metabolites from a large range of molecules that host’s enzymes are not able to convert. Among these molecules, two main classes of steroids, cholesterol and bile acids, denote two different examples of bacterial metabolism in the gut. Therefore, cholesterol is mainly converted into coprostanol, a non absorbable sterol which is excreted in the feces. Moreover, this conversion occurs in a part of the human population only. Conversely, the primary bile acids (cholic and chenodeoxycholic acids) are converted to over twenty different secondary bile acid metabolites by the gut microbiota. The main bile salt conversions, which appear in the gut of the whole human population, include deconjugation, oxidation and epimerization of hydroxyl groups at C3, C7 and C12, 7-dehydroxylation, esterification and desulfatation. If the metabolisms of cholesterol and bile acids by the gut microbiota are known for decades, their consequences on human health and disease are poorly understood and only start to be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, UDCA, which is produced by epimerization of CDCA, is thought to be chemopreventive44; and dietary supplementation with UDCA was reported to reduce experimentally induced hepatic carcinogenesis in rats.45”
From Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma (2022) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624 · cited 1×
“Moreover, the microbiome contains at least 100 times as many genes as the human genome [5], most of them serving human physiological functions.”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913 · cited 1×
“Using molecular techniques, it is now estimated that the human gastrointestinal tract harbors approximately 10(14) microorganisms (10 times more cells than the whole human body) and that this community is composed of 500 to 1000 distinct bacterial species [4].”
BackgroundDiversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533 · cited 1×
“three bacterial divisions, the Firmicutes (gram-positive), Bacteroidetes (gram-negative) and Actinobacteria (gram-positive) dominate the adult human gut microbiota [2].”
BackgroundDevelopment of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877 · cited 1×
“environment, the host genotype, and transition to an adult diet [1].”
BackgroundBile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829 · cited 3×
“BSH genes have been detected in the main bacterial genera of the gut microbiota [32] and the enzyme has been purified from Bacteroides fragilis, B. vulgatus, Clostridium perfringens, Listeria monocytogenes and several species of Lactobacillus and Bifidobacterium.”
BackgroundInfluentialThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · cited 1×
“It is now recognized that the communities of microbes in our gut function as an organ with many metabolic, immunologic and endocrine-like actions that influence human health [3].”
BackgroundObesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 1×
“Similarly, high levels of deoxycholic acid (known to cause DNA damage) in blood and feces are associated with increased risks of cholesterol gallstone disease and colon and liver cancer [46,47].”
BackgroundDietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904 · cited 1×
“Hence, it has been demonstrated that an increase in taurocholic acid, due to ingestion of milk fat, stimulates a sulphite-reducing pathobiont, Bilophila wadsworthia resulting in development of colitis in genetically susceptible mice that lacked interleukin-10 [50].”
BackgroundJones, B. V., Begley, M., Hill, C., Gahan, C. G. M., & Marchesi, J. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804437105 · Cited by 1,098 · cited 1×
“BSH genes have been detected in the main bacterial genera of the gut microbiota [32] and the enzyme has been purified from Bacteroides fragilis, B.”
BackgroundConnecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Duboc, H., Rajca, S., Rainteau, D., Benarous, D., Maubert, M.-A., Quervain, E., Thomas, G., Barbu, V., Humbert, L., Despras, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-302578 · Cited by 930 · cited 1×
“Recently, it was also demonstrated that the dysbiosis observed in inflammatory bowel disease lead to decreased bile acids deconjugation and desulfatation activities and then to a modification in the luminal bile acids pool composition which may contribute to chronic inflammation [48].”
Background
Cited by
Items 501–579 of 579
Analysis of Faecal Substrates Sheds Light into Coprostanol Origin, Preservation and Diagenesis
Sistiaga, A., Poyet, M., Groussin, M., Collins, M. J., & Summons, R. E. (2019) · International Meeting on Organic Geochemistry (IMOG) · doi:10.3997/2214-4609.201902866
Strawberries and Gut Health in Postmenopausal Women
MacNeill, M. T. (2019) · DigitalCommons - CalPoly (California State Polytechnic University) · doi:10.15368/theses.2019.62 · Cited by 2
The Role of Omic Technologies in the Study of the Human Gut Microbiome
Sen, P., Lamichhane, S., Dickens, A. M., & Orešič, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-100596-5.22922-3
Contributions des bactéries commensales et de l’hôte à la cholestérolémie
Lesnik, P. (2019) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2019.10.002
Kazemian, N., Ramezankhani, M., Sehgal, A., Khalid, F. M., Kalkhoran, A. H. Z., Narayan, A., Wong, G. K., Kao, D. H., & Pakpour, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.27.120386
“13 diversity of bacteria related to bile acid metabolizers (32).”
BackgroundMethodAlteration of Gut Microbiota in type 2 Diabetes Complicated with Cholelithiasis PatientsPreprint
Chen, J., Yan, L., Ma, X.-F., Yuan, P., Fan, Z., Han, Z., Liu, J., Wang, W., Zhou, D., Zhao, H., et al. (2020) · doi:10.21203/rs.3.rs-52504/v1
Bacterial succession and specialization within the poultry gastrointestinal tract
Maki, J. J. (2021) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210609-110
Gut Microbiota: The Servant of Human Being and the Accessary of Tumorigenesis
Gu, P., Li, D., Xu, G., Sun, Y., & Wu, M. (2020) · Trends in Oncology · doi:10.37155/2717-5278-0301-5
Diversity and Dynamics of the Gut Microbiome and Immune Cells
Pathak, P. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_4 · Cited by 1
Jin, W., & Fu, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1487214/v1
Zhang, H., Guan, W., Li, L., Guo, D., Xing, Q., Huang, C., Xiong, C., Li, B., Chen, K., & Peng, C. (2022) · Research Square · doi:10.21203/rs.3.rs-1515102/v1
Chiang, J. Y. L. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727446626.793538900
Biocatalysis and Pharmaceuticals: A Smart Tool for Sustainable Development
Alcántara, A. (2019) · MDPI eBooks · doi:10.3390/books978-3-03921-709-0 · Cited by 2
The etiology of gut dysbiosis and its role in chronic disease
Danenberg, A. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822238-6.00020-0
Wang, X. S., Li, P. X., Wang, B. S., Zhang, W. D., & Wang, W. H. (2023) · PeerJ · doi:10.7717/peerj.14647
“CA is a primary bile acid, while DCA and LCA are microbial-modified secondary bile acids that are involved in lipid absorption in the host intestine (Gérard, 2013).”
BackgroundCeylani, T., & Teker, H. T. (2023) · Bitlis Eren Üniversitesi Fen Bilimleri Dergisi · doi:10.17798/bitlisfen.1231238 · Cited by 1
“While the liver is responsible for synthesizing primary bile acids from cholesterol, several bacterial species in the intestines including Clostridium and Eubacterium are responsible for converting them into secondary bile acids [7].”
BackgroundHuman Microbiome and the Susceptibility to Infections
Anju, V. T., Busi, S., Mohan, M. S., & Dyavaiah, M. (2023) · Springer eBooks · doi:10.1007/978-981-99-1463-0_7 · Cited by 1
One Health Relationships in Microbe–Human Domain
Ambanpola, N., Seneviratne, K. N., & Jayathilaka, N. (2023) · One Health · doi:10.1002/9781119867333.ch11 · Cited by 2
Effect of ursodeoxycholic acid on the intestinal microbiota in children with chronic liver disease
Васильевна, В. Г., Nikitin, A. V., Андреевна, С. Т., Потапов, А. С., Валерьевна, Д. В., & Danilov, L. G. (2023) · Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) · doi:10.21508/1027-4065-2023-68-3-46-54
The Emerging Role of Microbiome in Cardiovascular Diseases
Shehata, E., & Day-Walsh, P. E. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815165012123010008
Chen, D., Tie, D., Fan, Z., Chen, X., Huang, F., Luo, H., Chen, J., Chen, Q., & Bo, H. (2023) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-023-02959-1
Intestinal Microbiome and Its Impact on Metabolism and Safety of Drugs
Chu, X. Y., & Ho, P. C. (2023) · Wiley eBooks · doi:10.1002/9781119660699.ch25 · Cited by 1
Cox, A. J., West, N. P., & Cripps, A. W. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch19
Interactions Between Gut Microbiota and Lipophilic Vitamins in Health and Disease
Datta, S., Boini, K. M., & Koka, S. (2024) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-55489-6_6
Alteration of ascending colon mucosal microbiota in patients after cholecystectomy
Fan, M.-Y., LÜ, Y., Cui, M.-Y., Zhao, M.-Q., Wang, J., Jiang, Q.-L., & Lü, Y. (2024) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v16.i8.2436 · Cited by 1
Microbiome-Immune Dynamics: Insights into Infectious Diseases
Rafinezhad, N. (2024) · SVOA Microbiology · doi:10.58624/svoamb.2024.05.048
“It acts as an anti - infectious barrier by preventing pathogen adherence and colonization and producing bacteriocins and other toxic metabolites [11].”
BackgroundMicrobiota and other detrimental metabolites in colorectal cancer
González, A., Fullaondo, A., Odriozola, I., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.006
Effect of exclusive enteral nutrition on gut microbiota in Malaysian children with Crohn’s disease
Wetthasinghe, L., Ng, H. F., Chew, K. S., & Lee, W. S. (2024) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/1408/1/012003
“Moreover, Eubacterium is proficient in metabolising bile acids (potentially in excess during the phase of active pCD, as bile acid dysbiosis is associated with CD) and cholesterol (from the consumption of a high-fat diet), contributing to intestinal homeostasis [33].”
Lin, Z., Zeng, H., Chen, T., & Li, Z. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19377
Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteriaPreprint
Mukherjee, S., Batagello, C., Adler, A., Agudelo, J., Zampini, A. M., Suryavanshi, M. V., Nguyen, A. H., Orr, T. J., Dearing, M. D., Monga, M., et al. (2025) · eLife · doi:10.7554/elife.104121.1
Complex system modelling reveals oxalate homeostasis is driven by diverse oxalate-degrading bacteriaPreprint
Mukherjee, S., Batagello, C., Adler, A., Agudelo, J., Zampini, A. M., Suryavanshi, M. V., Nguyen, A. H., Orr, T. J., Dearing, M. D., Monga, M., et al. (2025) · eLife · doi:10.7554/elife.104121.2 · Cited by 1
The Investigation into Correlation between Type 2 Diabetes Mellitus and the Gut Microbiota
Liu, S., & Zhu, A. M. (2025) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2025.1511022
Microbial rhythms – a new target to promote health?
Gorbunova, E., Heddes, M., van der Veen, D. R., & Kießling, S. (2025) · Trends in Microbiology · doi:10.1016/j.tim.2025.10.017
Guo, J., Xiao, J., Deng, F., Yu, H., Chen, S., Zhang, R., & Zhang, M. (2025) · Advanced Functional Foods · doi:10.64187/aff.2025010206
Joo, E.-J., Cheong, H. S., Kwon, M., Sohn, W., Kim, H.-N., & Cho, Y. K. (2021) · Figshare · doi:10.6084/m9.figshare.16909483
Jiang, D., He, X., Valitutto, M., Chen, L., Xu, Q., Yao, Y., Hou, R., & wang, H. (2020) · Figshare · doi:10.6084/m9.figshare.13332024
Naghipour, A., Amini‐Salehi, E., Orang Gorabzarmakhi, M., Shahdkar, M., Fouladi, B., Alipourfard, I., & Sanat, Z. M. (2024) · Figshare · doi:10.6084/m9.figshare.26611856
Mohieldeen, K., Hamoda, S. A. F., Ahmed, S. M., Najeeb, A., & Ellakany, W. I. (2021) · Figshare · doi:10.6084/m9.figshare.16696579
Probiotics for managing non-alcoholic fatty liver disease: efficacy and mechanistic insights
Ghosh, S., Ghosh, A. J., Adhikari, M. D., Tiwary, B. K., & Saha, T. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-026-01861-3
“The gut microbiota converts 1º BA [cholic acid (CA) and chenodeoxycholic acid (CDCA)] to 2º BA [deoxycholic acid (DCA), lithocholic acid (LCA) and ursodeoxycholic acid (UDCA)] [ 118, 119]. superoxide radicals (O₂-) and hydrogen peroxide (H 2 O 2 ) [100 ].”
Compositional Group Analysis of Biocrude Oils Obtained from Swine Manure by Slow Pyrolysis
Gonsalvesh, L., Marinov, S. P., Stefanova, M., Czech, J., Carleer, R., & Yperman, J. (2026) · Processes · doi:10.3390/pr14020382
Wang, M., Ye, X., Hsu, C.-Y., Fugate, H., Zhang, X., Adhikari, P. A., Fan, P. F., Elliott, K. E. C., Macklin, K., & Zhang, L. (2026) · Poultry Science · doi:10.1016/j.psj.2026.106527
“For example, Eubacterium coprostanoligenes , a CI-only species in our study (Table S5), is known to confer beneficial effects by converting cholesterol into coprostanol in the host gastrointestinal tract (Gerard, 2013).”
Sasia, S., Ortiz, M., Peña, M., Lumpkins, B. S., & Arguelles-Ramos, M. (2026) · Research in Veterinary Science · doi:10.1016/j.rvsc.2026.106130
Alikhan, H., White, B. E., Sterrett, J. D., Farag, M., Lowry, C. A., Dawud, L. M., Judge, T. A., Perez, L. J., DeSipio, J., & Phadtare, S. (2026) · Microorganisms · doi:10.3390/microorganisms14040801
“In particular, Bacteroides can decon-jugate bile acids with bile salt hydrolase, especially taurine-and glycine-conjugated bile acids, and they can oxidize, epimerize, and esterify bile acids [35,37–39].”
Microbiote intestinal, cancer du sein et métabolisme lipidique
Luu, T. H. (2018) · theses.fr (ABES) · doi:10.70675/5a95efcbzc6e9z41b8z84a5z058eda043638
Modulation de l'apport qualitatif post-natal en lipides sur le fonctionnement cérébral du nouveau-né
Aïdoud, N. (2018) · theses.fr (ABES) · doi:10.70675/6e8c9142za1bcz4dbcza6bfzebbdbfbac84a · Cited by 1
Interactions foie-intestin dans la cholangite sclérosante primitive
Kemgang, A. (2019) · theses.fr (ABES) · doi:10.70675/43488c90z3a87z4265z8aeaz1b3e77ed5a3b
The role of dietary sugars in intestinal homeostasis and microbiota composition
Zhang, X. (2018) · theses.fr (ABES) · doi:10.70675/bad688b4zdd65z4520zb77cz975f29622456 · Cited by 2
Impact du microbiome intestinal sur la cholestérolémie : concepts et applications
Bourgin, M. (2021) · theses.fr (ABES) · doi:10.70675/5ef61a78z31c7z44fazafa1zd4a5749a4aaf
Mariaule, V. (2024) · theses.fr (ABES) · doi:10.70675/1d41e841zf788z4dd7z8784zc26304e24ea1
Yan, J., Jiang, L., Li, Y., Lv, H., Wu, W., Yang, L., Chen, J., & Ding, S. (2026) · Microorganisms · doi:10.3390/microorganisms14051076
Mir-Makhamad, B., Vassão, D. G., Arbach-Benz, D., Shoaee, M. J., Tang, L., Amano, N., Nakamura, Y., Paetz, C., Nganyalila, A. M., Mwambwiga, A., et al. (2026) · Archaeological and Anthropological Sciences · doi:10.1007/s12520-026-02490-w
“This oxidation typically occurred at carbon positions C3, C6, C7, or C12 (Gérard 2013).”
The Role of Selected Bacteria in Breast Cancer Initiation and Development
Gebretsadik, G., Islam, S., Szpendyk, J., Thomas, V. D., & Furuta, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104585
“These bacteria also participate in bile acid metabolism; species such as C. scindens and C. hiranonis convert primary bile acids into secondary forms like deoxy-cholic acid (DCA), shaping host metabolism and immune responses [172,173].”
Yang, W., Yong, S., Zhang, Q., Zhang, W., Zhou, Q., Tan, X., & Xu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1814676
“The microbiota transforms dietary components into various bioactive metabolites, such as short-chain fatty acids (SCFAs) (30), secondary bile acids (31), and indole derivatives (32).”
Yu, Q., Ding, H., Chen, Y., & Gao, X. (2026) · PeerJ · doi:10.7717/peerj.21195
“Other bacterial actions include oxidation and epimerization, often associated with intestinal Firmicutes , Bacteroidetes , and Escherichia ( Gérard, 2013 ; Ridlon et al., 2020 , 2016 ).”
Wang, S., Li, Z., Wang, Y., Mai, M., Ruan, R., & Guo, H. (2026) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2026.103601
Sobky, S. A. E., El-Ekiaby, N. M., Fawzy, I. O., Abdelhamid, A. K., Attia, H., Fayed, I. H., Badr, Y., Emadeldeen, M., Nagy, A., Negm, M., et al. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1703547
“Finally, Eubacterium was linked to several human diseases and to BA and cholesterol modifications in the gut (Gerard, 2013; Mukherjee et al., 2020).”
Piccirelli, S., Barberio, B., Tettoni, E., Treppiccione, C., Pezzuto, E., Tabbone, E., Salvi, D., Bertin, L., Gerardi, V., Cesaro, P., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19071045 · Cited by 1
Management of Type 2 Diabetes Mellitus: Targeting Gut Microbiome Therapy
Bibi, A., Zhou, L., You, M., Niu, H., Tasleem, M. W., Wu, H., & Zhang, H. (2026) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x26500497
Cannon, M. L., Peldyak, J., & Campbell, E. (2026) · Metabolites · doi:10.3390/metabo16070495
“Other bacteria either incorporate cholesterol into bacterial membranes or convert cholesterol to co-prostanol, a sterol that is less efficiently absorbed by the host [24–26].”
Microbiota and lipid mediators: from molecular crosstalk to therapeutic opportunities
Gökcen, B. B., Atabılen, B., Güneş, B. D., Dazıroğlu, M. E. Ç., Özer, Ş. D., Biten, A. A., Pagano, E., Nanì, M. F., Romano, B., Ağagündüz, D., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1836931
“…occurs through three major enzymatic steps: (1) deconjugation mediated by bacterial bile salt hydrolases (BSHs), (2) 7 α -dehydroxylation through sequential enzymatic reactions, and (3) epimerization via hydroxysteroid dehydrogenases (Fleishman and Kumar, 2024; Chiang, 2013; Gérard, 2013).”
Gut-liver axis and intestinal microbiota: Key targets of herbal medicines in treatment of MASLD/MASH
Mao, Y., Wei, C., Zhang, Y., Zheng, Y., Ji, R., Ge, L. I. N., He, X., He, Y., Yang, J., & Ma, J. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.08.017 · Cited by 2
Interplay of gut microbiota, immune cells and natural products in reshaping cancer immunotherapy
Wu, X., Lu, L., Li, T., Zhao, L., Wang, L., Yao, Y., Chen, J., Liu, T., Li, X., Zhu, X., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1898063
“They regulate diverse physiological processes through nuclear receptors such as farnesoid X receptor (FXR) and pregnane X receptor (PXR), as well as membrane receptors including TGR5 and S1PR2, thereby influencing metabolic and immune homeostasis (Gérard, 2013; Jia et al., 2021).”
Decoding the Biological Function of Bile Acids for Drug Discovery
Yang, J., & Lei, X. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00477
Fibres alimentaires, microbiote et acides biliaires : interactions et impacts sur la santé
Makki, K., & Michalski, M. (2026) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2026.08.111
Zhang, W., Matuszek, G., Dolnikowski, G. G., Lamon‐Fava, S., Ausman, L. M., Lichtenstein, A. H., & Matthan, N. R. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101561
Hussein, D. K., El‐Shiekh, R. A., Okba, M. M., Abou-Hussein, D. R., Nagaty, H. A., El-Kashoury, E.-S. A., & Attia, H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.110200
Chen, X., Jiang, L., Li, A., & Shen, J. (2026) · Microorganisms · doi:10.3390/microorganisms14102330
“Lactobacillus has the ability to produce BSH, which catalyzes the conversion of conjugated primary BAs to nonconverted secondary BAs, thereby reducing the reabsorption of BAs in the enterohepatic circulation [16].”
Effects of social rearing systems on the gut microbiome of dairy calves before and after weaning
Costa, B. G., Rutschke, S., Endres, M. I., Gomez, A., & Heins, B. J. (2026) · Journal of Dairy Science · doi:10.3168/jds.2026-28497
Xiang, H., He, T., Dou, Y., Chen, Q., Wu, P., Luo, Z., Xiang, H., & Zhang, J. (2026) · Pathogens · doi:10.3390/pathogens15111128
Metadata
- Authors
- Gérard, P.
- Affiliations
- AgroParisTech (FR)
- Corresponding author
- Gérard, Philippe
- ORCID
- Gérard, Philippe
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2013-12-30
- Volume
- 3
- Issue
- 1
- Pages
- 14-24
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC4235735
- OpenAlex
- W1979308600
- Cited by
- 580
- References
- 52
- Citations by year
- 2026: 40 · 2025: 41 · 2024: 53 · 2023: 54 · 2022: 70 · 2021: 76 · 2020: 74 · 2019: 53 · 2018: 51 · 2017: 24 · 2016: 24 · 2015: 15 · 2014: 5
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- gut microbiota, cholesterol metabolism, bile acid metabolism, coprostanol, secondary bile acids, bile acid deconjugation, human gut microbiome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

